Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial by Dutton, Susan J, MSc, Ferry, David R, Prof, Blazeby, Jane M, Prof, Abbas, Haider, MRCP, Dahle-Smith, Asa, MBChB, Mansoor, Wasat, PhD, Thompson, Joyce, FRCP, Harrison, Mark, PhD, Chatterjee, Anirban, FRCR, Falk, Stephen, MD, Garcia-Alonso, Angel, MD, Fyfe, David W, MD, Hubner, Richard A, PhD, Gamble, Tina, Peachey, Lynnda, BSc, Davoudianfar, Mina, BA, Pearson, Sarah R, BSc, Julier, Patrick, MSc, Jankowski, Janusz, Prof, Kerr, Rachel, MD, Petty, Russell D, MRCP

Get full text